Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study

Title
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study
Authors
Keywords
Non-Hodgkin lymphoma, Rituximab, Fludarabine, Hypogammaglobulinemia
Journal
LEUKEMIA RESEARCH
Volume 39, Issue 12, Pages 1382-1388
Publisher
Elsevier BV
Online
2015-11-05
DOI
10.1016/j.leukres.2015.10.013

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search